Antibiotic resistance has created an imminent need for innovative approaches for prevention and therapy of nosocomial infections. Monoclonal antibodies (mAbs) are an increasingly promising strategy, but many hurdles in the development of these products remain. This free online workshop will provide an open discussion forum to identify and prioritize specific challenges and propose mitigation strategies to be implemented in future developments. Investigators from industry, academia, regulatory agencies and public health bodies working in preclinical or clinical development of mAbs for infectious diseases are invited to join.

Please register (separately for each day) at the links below.